Forms of Rifaximin and uses thereof

Details for Australian Patent Application No. 2011218258 (hide)

Owner Salix Pharmaceuticals, Ltd.

Inventors Gushurst, Karen S.; Yang, Donglai; Vlahova, Petinka; Stults, Jeffrey S.

Agent Pizzeys

Pub. Number AU-A-2011218258

PCT Pub. Number WO2011/103120

Priority 12/708,836 19.02.10 US

Filing date 16 February 2011

Wipo publication date 25 August 2011

International Classifications

C07D 498/00 Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

30 August 2012 PCT application entered the National Phase

  PCT publication WO2011/103120 Priority application(s): WO2011/103120

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011218262-Microbe mitigating architectural barriers, compositions for forming such barriers and related methods

2011218256-Utility grid command filter system